Login / Signup

Effects of ABCB1 polymorphisms on the transport of ponatinib into the cerebrospinal fluid in Japanese Philadelphia chromosome-positive acute lymphoblastic leukaemia patients.

Yayoi FukushiYumiko AkamineMaiko AbumiyaNagi TozawaTakaya YamashitaMiho NaraYoshihiro KameokaNaoto TakahashiMasatomo Miura
Published in: British journal of clinical pharmacology (2022)
The effects of polymorphisms of ABCB1 and ABCG2 on the dose-adjusted plasma trough concentrations and cerebrospinal fluid (CSF)-to-plasma ratios of ponatinib were evaluated. Blood (C 4 ) and CSF (CSF 4 ) concentrations at 4 h after administration were determined. The median (95% confidence interval (CI)) CSF 4 -to-C 4 ratio of ponatinib in subjects homozygous for ABCB1 variants 1236T/T, 2677T/T+T/A, or 3435T/T were significantly higher than that in a group of subjects with other genotypes (P = 0.026, 0.012, and 0.015, respectively). The median (95% CI) CSF 4 -to-C 4 ratio of ponatinib in four patients with the combination of ABCB1 variants 1236T/T-2677T/T+T/A-3435T/T was 2.62 (1.42 - 3.42)%; this ratio was significantly higher than that in subjects with other genotypes [1.08 (0.89 - 1.47)%; P = 0.006]. The brain distribution of ponatinib was affected by ABCB1 polymorphisms and therefore seems to be modulated by P-glycoprotein at the blood-brain and blood-CSF barriers.
Keyphrases